O'Connor Daniel

Avg. Two Year Performance

77% Avg. Purchase Return
33% Compound
30% Avg. Sale Return
14% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(10%)(13%)(15%)162%77%
Purchase Success Rate0 of 21 of 21 of 21 of 21 of 2
Average Sale Return(< 1%)5%8%11%30%
Sale Success Rate7 of 135 of 133 of 133 of 135 of 13
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 618.35K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CEO and President, Director:

Holdings: 96.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

President and CEO, Director:

Holdings: 2.75M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

SVP, Interim Gen. Counsel, Sec:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director, 10% Owner:

Holdings: 1.38M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

Director:

Holdings: 16.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--